Does GATA3 act in tissue-specific pathways A meta-analysis-based approach

Journal of Carcinogenesis

Volumn 7, Issue , 2008, Pages

  Wilson, Brian ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

co expression; GATA3; meta analysis; p63; tissue specific; transcription

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; RENIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; COMPUTER MODEL; HUMAN; LEUKEMIA; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TISSUE SPECIFICITY;

EID: 77956583864     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.43426     Document Type: Article

References (40)

1. Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, et al. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res 2005;65:11259-64.
2. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M. Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res 2007;67:6477-83.
3. Engelsen IB, Stefansson IM, Akslen LA, Salvesen HB. GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. Am J Obstet Gynecol 2008.
4. Wilson BJ, Giguere V. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer 2008;7:49.
5. Wilson BJ, Giguere V. Identification of novel pathway partners of p68 and p72 RNA helicases through Oncomine meta-analysis. BMC Genomics 2007;8:419.
6. Wilson BJ. Meta-analysis of SUMO1. BMC Res Notes 2008;1:60.
7. Minegishi N, Morita S, Minegishi M, Tsuchiya S, Konno T, Hayashi N, et al. Expression of GATA transcription factors in myelogenous and lymphoblastic leukemia cells. Int J Hematol 1997;65:239-49.
8. Chen ML, Kuo CL. A conserved sequence block in the murine and human T cell receptor Jalpha loci interacts with developmentally regulated nucleoprotein complexes in vitro and associates with GATA-3 and octamer-binding factors in vivo. Eur J Immunol 2001;31:1696-705.
9. Marine J, Winoto A. The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements. Proc Natl Acad Sci U S A 1991;88:7284-8.
10. Joulin V, Bories D, Eleouet JF, Labastie MC, Chretien S, Mattei MG, et al. A T-cell specific TCR delta DNA binding protein is a member of the human GATA family. Embo J 1991;10:1809-16.
11. Bots M, Medema JP. Granzymes at a glance. J Cell Sci 2006;119:5011-4.
12. Zhu J, Cote-Sierra J, Guo L, Paul WE. Stat5 activation plays a critical role in Th2 differentiation. Immunity 2003;19:739-48.
13. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, et al. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 1995;11:40-4.
14. Nardelli J, Thiesson D, Fujiwara Y, Tsai FY, Orkin SH. Expression and genetic interaction of transcription factors GATA-2 and GATA-3 during development of the mouse central nervous system. Dev Biol 1999;210:305-21.
15. Pata I, Studer M, van Doorninck JH, Briscoe J, Kuuse S, Engel JD, et al. The transcription factor GATA3 is a downstream effector of Hoxb1 specification in rhombomere 4. Development 1999;126:5523-31.
16. Zhao GY, Li ZY, Zou HL, Hu ZL, Song NN, Zheng MH, et al. Expression of the transcription factor GATA3 in the postnatal mouse central nervous system. Neurosci Res 2008;61:420-8.
17. Mukhopadhyay M, Pelka P, DeSousa D, Kablar B, Schindler A, Rudnicki MA, et al. Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog. Gene 2002;293:59-65.
18. Akhmametyeva EM, Mihaylova MM, Luo H, Kharzai S, Welling DB, Chang LS. Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development. Dev Dyn 2006;235:2771-85.
19. Uppal S, Coatesworth AP. Neurofibromatosis type 2. Int J Clin Pract 2003;57:698-703.
20. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 2000;406:419-22.
21. Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, et al. GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. J Med Genet 2001;38:374-80.
22. Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C, et al. Characterization of GATA3 mutations in the hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome. J Biol Chem 2004;279:22624-34.
23. Labastie MC, Catala M, Gregoire JM, Peault B. The GATA-3 gene is expressed during human kidney embryogenesis. Kidney Int 1995;47:1597-603.
24. George KM, Leonard MW, Roth ME, Lieuw KH, Kioussis D, Grosveld F, et al. Embryonic expression and cloning of the murine GATA-3 gene. Development 1994;120:2673-86.
25. Grote D, Souabni A, Busslinger M, Bouchard M. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 2006;133:53-61.
26. Muto S. Potassium transport in the mammalian collecting duct. Physiol Rev 2001;81:85-116.
27. Ji W, Foo JN, O′Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008;40:592-9.
28. Thompson M, Lapointe J, Choi YL, Ong DE, Higgins JP, Brooks JD, et al. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. Prostate 2008;68:1248-56.
29. Perez-Stable CM, Pozas A, Roos BA. A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer. Mol Cell Endocrinol 2000;167:43-53.
30. Senoo M, Pinto F, Crum CP, McKeon F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007;129:523-36.
31. Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, et al. Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 2007;31:673-80.
32. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007;26:6979-88.
33. Anose BM, LaGoo L, Schwendinger J. Characterization of androgen regulation of ZEB-1 and PSA in 22RV1 prostate cancer cells. Adv Exp Med Biol 2008;617:541-6.
34. Gregoire JM, Romeo PH. T-cell expression of the human GATA-3 gene is regulated by a non-lineage-specific silencer. J Biol Chem 1999;274:6567-78.
35. Bonkhoff H, Stein U, Welter C, Remberger K. Differential expression of the pS2 protein in the human prostate and prostate cancer: Association with premalignant changes and neuroendocrine differentiation. Hum Pathol 1995;26:824-8.
36. Colombel M, Dante R, Bouvier R, Ribieras S, Pangaud C, Marechal JM, et al. Differential RNA expression of the pS2 gene in the human benign and malignant prostatic tissue. J Urol 1999;162:927-30. (Pubitemid 29436919)
37. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: A gene expression analysis on total and microdissected prostate tissue. Am J Pathol 2002;160:2169-80.
38. Hosoi Y, Kapp LN, Murnane JP, Matsumoto Y, Enomoto A, Ono T, et al. Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene, ATDC. Biochem Biophys Res Commun 2006;348:728-34.
39. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 2006;127:1041-55.
40. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007;9:201-9.